U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423078) titled 'Window of Opportunity in Preserving Laryngeal Function Trial' on Feb. 06.
Brief Summary: This trial will study the safety and tolerability and disease survival rates in adult patients with recurrent/metastatic (R/M) HNSCC when treated with carboplatin or cisplatin, paclitaxel, and toripalimab.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Locally Advanced Laryngeal Squamous Cell Carcinoma
Hypopharyngeal Squamous Cell Carcinoma
Intervention:
DRUG: Toripalimab
A monoclonal antibody (recombinant humanized programmed cell death protein 1...